AST 0 3 0 3 B-clinical_variable
/ 3 4 3 4 I-clinical_variable
ALT 4 7 4 7 I-clinical_variable
≤2.5 8 12 8 12 O
× 13 14 13 14 I-upper_bound
ULN 15 18 15 18 I-upper_bound

Age 0 3 19 22 B-age
≥18 4 7 23 26 O
years 8 13 27 32 I-lower_bound

Concurrent 0 10 33 43 O
anticancer 11 21 44 54 B-treatment
therapy 22 29 55 62 I-treatment
( 30 31 63 64 O
including 31 40 64 73 O
other 41 46 74 79 O
investigational 47 62 80 95 B-treatment
agents 63 69 96 102 I-treatment
) 69 70 102 103 O

DLCO 0 4 104 108 B-clinical_variable
/ 4 5 108 109 I-clinical_variable
VA 5 7 109 111 I-clinical_variable
and 8 11 112 115 O
FEV1 12 16 116 120 B-clinical_variable
≥ 17 18 121 122 O
50 19 21 123 125 B-lower_bound
% 21 22 125 126 I-lower_bound
of 23 25 127 129 O
predicted 26 35 130 139 O
on 36 38 140 142 O
PFTs 39 43 143 147 O

ECOG 0 4 148 152 B-clinical_variable
performance 5 16 153 164 I-clinical_variable
status 17 23 165 171 I-clinical_variable
≤1 24 26 172 174 O
( 27 28 175 176 O
Karnofsky 28 37 176 185 B-clinical_variable
≥70 38 41 186 189 O
% 41 42 189 190 I-lower_bound
) 42 43 190 191 O

Evaluable 0 9 192 201 O
or 10 12 202 204 O
measurable 13 23 205 215 B-chronic_disease
disease 24 31 216 223 I-chronic_disease
, 31 32 223 224 O
defined 33 40 225 232 O
as 41 43 233 235 O
by 44 46 236 238 O
Response 47 55 239 247 O
Evaluation 56 66 248 258 O
Criteria 67 75 259 267 O
in 76 78 268 270 O
Solid 79 84 271 276 O
Tumors 85 91 277 283 O
( 92 93 284 285 O
RECIST 93 99 285 291 O
) 99 100 291 292 O

HIV 0 3 293 296 B-chronic_disease
positive 4 12 297 305 O
patients 13 21 306 314 O

Histologically 0 14 315 329 O
confirmed 15 24 330 339 O
solid 25 30 340 345 B-cancer
tumor 31 36 346 351 I-cancer
malignancy 37 47 352 362 B-cancer
that 48 52 363 367 O
is 53 55 368 370 O
metastatic 56 66 371 381 B-cancer
or 67 69 382 384 O
unresectable 70 82 385 397 O
and 83 86 398 401 O
have 87 91 402 406 O
progressed 92 102 407 417 O
on 103 105 418 420 O
at 106 108 421 423 O
least 109 114 424 429 O
1 115 116 430 431 B-lower_bound
prior 117 122 432 437 I-lower_bound
therapy 123 130 438 445 B-treatment
and 131 134 446 449 O
for 135 138 450 453 O
whom 139 143 454 458 O
standard 144 152 459 467 O
curative 153 161 468 476 O
or 162 164 477 479 O
palliative 165 175 480 490 O
measures 176 184 491 499 O
do 185 187 500 502 O
not 188 191 503 506 O
exist 192 197 507 512 O
or 198 200 513 515 O
are 201 204 516 519 O
associated 205 215 520 530 O
with 216 220 531 535 O
minimal 221 228 536 543 O
subject 229 236 544 551 O
survival 237 245 552 560 O
benefit 246 253 561 568 O

History 0 7 569 576 O
of 8 10 577 579 O
allergic 11 19 580 588 O
reactions 20 29 589 598 O
attributed 30 40 599 609 O
to 41 43 610 612 O
compounds 44 53 613 622 B-allergy_name
of 54 56 623 625 I-allergy_name
similar 57 64 626 633 I-allergy_name
chemical 65 73 634 642 I-allergy_name
or 74 76 643 645 I-allergy_name
biologic 77 85 646 654 I-allergy_name
composition 86 97 655 666 I-allergy_name
to 98 100 667 669 I-allergy_name
hetIL-15 101 109 670 678 I-allergy_name

History 0 7 679 686 O
of 8 10 687 689 O
autoimmune 11 21 690 700 B-chronic_disease
disease 22 29 701 708 I-chronic_disease

History 0 7 709 716 O
of 8 10 717 719 O
severe 11 17 720 726 O
asthma 18 24 727 733 B-chronic_disease
or 25 27 734 736 O
absolute 28 36 737 745 O
requirement 37 48 746 757 O
for 49 52 758 761 O
chronic 53 60 762 769 O
inhaled 61 68 770 777 O
corticosteroid 69 83 778 792 B-treatment
medications 84 95 793 804 I-treatment

Life 0 4 805 809 B-clinical_variable
expectancy 5 15 810 820 I-clinical_variable
> 16 17 821 822 O
3 18 19 823 824 B-lower_bound
months 20 26 825 831 I-lower_bound

Positive 0 8 832 840 O
hepatitis 9 18 841 850 B-chronic_disease
B 19 20 851 852 I-chronic_disease
or 21 23 853 855 O
C 24 25 856 857 B-chronic_disease
serology 26 34 858 866 O

Primary 0 7 867 874 O
brain 8 13 875 880 B-cancer
cancers 14 21 881 888 I-cancer
or 22 24 889 891 O
active 25 31 892 898 O
CNS 32 35 899 902 B-cancer
metastases 36 46 903 913 I-cancer

Prior 0 5 914 919 B-treatment
IL-15 6 11 920 925 I-treatment
treatment 12 21 926 935 I-treatment
or 22 24 936 938 O
cytotoxic 25 34 939 948 B-treatment
therapy 35 42 949 956 I-treatment
, 42 43 956 957 O
immunotherapy 44 57 958 971 B-treatment
, 57 58 971 972 O
radiotherapy 59 71 973 985 B-treatment
, 71 72 985 986 O
major 73 78 987 992 B-treatment
surgery 79 86 993 1000 I-treatment
, 86 87 1000 1001 O
antitumor 88 97 1002 1011 B-treatment
vaccines 98 106 1012 1020 I-treatment
or 107 109 1021 1023 O
monoclonal 110 120 1024 1034 B-treatment
antibodies 121 131 1035 1045 I-treatment
in 132 134 1046 1048 O
the 135 138 1049 1052 O
4 139 140 1053 1054 B-upper_bound
weeks 141 146 1055 1060 I-upper_bound
prior 147 152 1061 1066 I-upper_bound
or 153 155 1067 1069 O
for 156 159 1070 1073 O
checkpoint 160 170 1074 1084 O
inhibitors 171 181 1085 1095 O
such 182 186 1096 1100 O
as 187 189 1101 1103 O
anti 190 194 1104 1108 B-treatment
- 194 195 1108 1109 I-treatment
CTLA-4 195 201 1109 1115 I-treatment
or 202 204 1116 1118 O
anti 205 209 1119 1123 B-treatment
PD1 210 213 1124 1127 I-treatment
/ 213 214 1127 1128 I-treatment
PD 214 216 1128 1130 I-treatment
- 216 217 1130 1131 I-treatment
L1 217 219 1131 1133 I-treatment
or 220 222 1134 1136 O
nitrosoureas 223 235 1137 1149 B-treatment
or 236 238 1150 1152 O
mitomycin 239 248 1153 1162 B-treatment
C 249 250 1163 1164 I-treatment
for 251 254 1165 1168 O
6 255 256 1169 1170 B-upper_bound
weeks 257 262 1171 1176 I-upper_bound
prior 263 268 1177 1182 I-upper_bound
to 269 271 1183 1185 O
C1D1 272 276 1186 1190 O

Recovered 0 9 1191 1200 O
to 10 12 1201 1203 O
≤ 13 14 1204 1205 O
grade 15 20 1206 1211 B-upper_bound
1 21 22 1212 1213 I-upper_bound
NCI 23 26 1214 1217 B-clinical_variable
CTCAE 27 32 1218 1223 I-clinical_variable
version 33 40 1224 1231 O
4.0 41 44 1232 1235 O
from 45 49 1236 1240 O
toxicity 50 58 1241 1249 O
of 59 61 1250 1252 O
prior 62 67 1253 1258 B-treatment
chemotherapy 68 80 1259 1271 I-treatment
or 81 83 1272 1274 O
biologic 84 92 1275 1283 B-treatment
therapy 93 100 1284 1291 I-treatment
administered 101 113 1292 1304 O
more 114 118 1305 1309 O
than 119 123 1310 1314 O
4 124 125 1315 1316 B-lower_bound
weeks 126 131 1317 1322 I-lower_bound
earlier 132 139 1323 1330 O

Subjects 0 8 1331 1339 O
on 9 11 1340 1342 O
bisphosphonates 12 27 1343 1358 B-treatment
for 28 31 1359 1362 O
any 32 35 1363 1366 O
cancer 36 42 1367 1373 B-cancer
or 43 45 1374 1376 O
on 46 48 1377 1379 O
hormone 49 56 1380 1387 B-treatment
therapy 57 64 1388 1395 I-treatment
for 65 68 1396 1399 O
prostate 69 77 1400 1408 B-cancer
cancer 78 84 1409 1415 I-cancer
may 85 88 1416 1419 O
continue 89 97 1420 1428 O
this 98 102 1429 1433 O
therapy 103 110 1434 1441 O

Subjects 0 8 1442 1450 O
with 9 13 1451 1455 O
inactive 14 22 1456 1464 O
central 23 30 1465 1472 B-cancer
nervous 31 38 1473 1480 I-cancer
system 39 45 1481 1487 I-cancer
( 46 47 1488 1489 I-cancer
CNS 47 50 1489 1492 I-cancer
) 50 51 1492 1493 I-cancer
metastasis 52 62 1494 1504 I-cancer

Uncontrolled 0 12 1505 1517 O
intercurrent 13 25 1518 1530 O
illness 26 33 1531 1538 O
including 34 43 1539 1548 O
, 43 44 1548 1549 O
but 45 48 1550 1553 O
not 49 52 1554 1557 O
limited 53 60 1558 1565 O
to 61 63 1566 1568 O
, 63 64 1568 1569 O
ongoing 65 72 1570 1577 O
or 73 75 1578 1580 O
active 76 82 1581 1587 B-chronic_disease
infection 83 92 1588 1597 I-chronic_disease
, 92 93 1597 1598 O
symptomatic 94 105 1599 1610 O
congestive 106 116 1611 1621 B-chronic_disease
heart 117 122 1622 1627 I-chronic_disease
failure 123 130 1628 1635 I-chronic_disease
, 130 131 1635 1636 O
unstable 132 140 1637 1645 B-chronic_disease
angina 141 147 1646 1652 I-chronic_disease
pectoris 148 156 1653 1661 I-chronic_disease
, 156 157 1661 1662 O
cardiac 158 165 1663 1670 B-chronic_disease
arrhythmia 166 176 1671 1681 I-chronic_disease
, 176 177 1681 1682 O
cognitive 178 187 1683 1692 B-chronic_disease
impairment 188 198 1693 1703 I-chronic_disease
, 198 199 1703 1704 O
active 200 206 1705 1711 O
substance 207 216 1712 1721 O
abuse 217 222 1722 1727 O
, 222 223 1727 1728 O
or 224 226 1729 1731 O
psychiatric 227 238 1732 1743 B-chronic_disease
illness 239 246 1744 1751 I-chronic_disease
/ 246 247 1751 1752 O
social 247 253 1752 1758 O
situations 254 264 1759 1769 O
that 265 269 1770 1774 O
, 269 270 1774 1775 O
in 271 273 1776 1778 O
the 274 277 1779 1782 O
view 278 282 1783 1787 O
of 283 285 1788 1790 O
the 286 289 1791 1794 O
Investigator 290 302 1795 1807 O
, 302 303 1807 1808 O
would 304 309 1809 1814 O
preclude 310 318 1815 1823 O
safe 319 323 1824 1828 O
treatment 324 333 1829 1838 B-treatment
or 334 336 1839 1841 O
the 337 340 1842 1845 O
ability 341 348 1846 1853 O
to 349 351 1854 1856 O
give 352 356 1857 1861 O
informed 357 365 1862 1870 O
consent 366 373 1871 1878 O
and 374 377 1879 1882 O
limit 378 383 1883 1888 O
compliance 384 394 1889 1899 O
with 395 399 1900 1904 O
study 400 405 1905 1910 O
requirements 406 418 1911 1923 O

Women 0 5 1924 1929 B-gender
of 6 8 1930 1932 O
child 9 14 1933 1938 O
- 14 15 1938 1939 O
bearing 15 22 1939 1946 O
potential 23 32 1947 1956 O
and 33 36 1957 1960 O
men 37 40 1961 1964 O
must 41 45 1965 1969 O
agree 46 51 1970 1975 B-contraception_consent
to 52 54 1976 1978 I-contraception_consent
use 55 58 1979 1982 I-contraception_consent
adequate 59 67 1983 1991 I-contraception_consent
contraception 68 81 1992 2005 I-contraception_consent
prior 82 87 2006 2011 O
to 88 90 2012 2014 O
study 91 96 2015 2020 O
entry 97 102 2021 2026 O
, 102 103 2026 2027 O
during 104 110 2028 2034 O
the 111 114 2035 2038 O
treatment 115 124 2039 2048 B-treatment
portion 125 132 2049 2056 O
of 133 135 2057 2059 O
the 136 139 2060 2063 O
study 140 145 2064 2069 O
and 146 149 2070 2073 O
for 150 153 2074 2077 O
4 154 155 2078 2079 B-upper_bound
months 156 162 2080 2086 I-upper_bound
after 163 168 2087 2092 I-upper_bound
completion 169 179 2093 2103 O
of 180 182 2104 2106 O
hetIL-15 183 191 2107 2115 O
administration 192 206 2116 2130 O

absolute 0 8 2131 2139 B-clinical_variable
neutrophil 9 19 2140 2150 I-clinical_variable
count 20 25 2151 2156 I-clinical_variable
( 26 27 2157 2158 I-clinical_variable
ANC 27 30 2158 2161 I-clinical_variable
) 30 31 2161 2162 I-clinical_variable
≥1,500 32 38 2163 2169 O
/ 38 39 2169 2170 I-lower_bound
mcL 39 42 2170 2173 I-lower_bound

autoimmune 0 10 2174 2184 O
event 11 16 2185 2190 O
associated 17 27 2191 2201 O
with 28 32 2202 2206 O
prior 33 38 2207 2212 B-treatment
ipilimumab 39 49 2213 2223 I-treatment
( 50 51 2224 2225 I-treatment
anti 51 55 2225 2229 I-treatment
- 55 56 2229 2230 I-treatment
CTLA-4 56 62 2230 2236 I-treatment
) 62 63 2236 2237 I-treatment
therapy 64 71 2238 2245 I-treatment
that 72 76 2246 2250 O
has 77 80 2251 2254 O
been 81 85 2255 2259 O
completely 86 96 2260 2270 O
resolved 97 105 2271 2279 O
for 106 109 2280 2283 O
more 110 114 2284 2288 O
than 115 119 2289 2293 O
4 120 121 2294 2295 B-lower_bound
weeks 122 127 2296 2301 I-lower_bound
prior 128 133 2302 2307 I-lower_bound
to 134 136 2308 2310 O
C1D1 137 141 2311 2315 O

creatinine 0 10 2316 2326 B-clinical_variable
< 11 12 2327 2328 O
1.5 12 15 2328 2331 B-upper_bound
× 16 17 2332 2333 I-upper_bound
institutional 18 31 2334 2347 I-upper_bound
ULN 32 35 2348 2351 I-upper_bound

creatinine 0 10 2352 2362 B-clinical_variable
clearance 11 20 2363 2372 I-clinical_variable
≥60 21 24 2373 2376 O
mL 25 27 2377 2379 I-lower_bound
/ 27 28 2379 2380 I-lower_bound
min/1.73 28 36 2380 2388 I-lower_bound
m2 37 39 2389 2391 I-lower_bound
for 40 43 2392 2395 O
subjects 44 52 2396 2404 O
with 53 57 2405 2409 O
serum 58 63 2410 2415 B-clinical_variable
creatinine 64 74 2416 2426 I-clinical_variable
levels 75 81 2427 2433 I-clinical_variable
> 82 83 2434 2435 O
1.5 83 86 2435 2438 B-lower_bound
× 87 88 2439 2440 I-lower_bound
higher 89 95 2441 2447 I-lower_bound
than 96 100 2448 2452 I-lower_bound
ULN 101 104 2453 2456 I-lower_bound

hormone 0 7 2457 2464 B-treatment
therapy 8 15 2465 2472 I-treatment
for 16 19 2473 2476 O
prostate 20 28 2477 2485 B-cancer
cancer 29 35 2486 2492 I-cancer

leukocytes 0 10 2493 2503 B-clinical_variable
≥3,000 11 17 2504 2510 O
/ 17 18 2510 2511 I-lower_bound
mcL 18 21 2511 2514 I-lower_bound

platelets 0 9 2515 2524 B-clinical_variable
≥100,000 10 18 2525 2533 O
/ 18 19 2533 2534 I-lower_bound
mcL 19 22 2534 2537 I-lower_bound

total 0 5 2538 2543 B-clinical_variable
bilirubin 6 15 2544 2553 I-clinical_variable
within 16 22 2554 2560 O
normal 23 29 2561 2567 O
institutional 30 43 2568 2581 O
limits 44 50 2582 2588 O

